ArticleTherapeutic advances in medical oncology2020

Clinical and molecular distinctions in patients with refractory colon cancer who benefit from regorafenib treatment.

Min-Sang Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.